Ross M. Hays, MD

Dr. Hays was primary investigator of the Robert Wood Johnson Promoting Excellence in End-of-Life Care Program. He is board certified in pediatrics, rehabilitation medicine and hospice and palliative care.  Dr. Hays has been principal investigator on a trial using botulinum toxin to improve function for children with cerebral palsy and co-investigator in a study of the efficacy of selective dorsal rhizotomy in the treatment of cerebral palsy. He has participated in research investigating pain and painful procedures in children and projects to improve education on chronic disease and disability.  Dr. Hays is the pediatric clinical core leader for the Seattle Cancer Care Alliance’s Muscular Dystrophy Cooperative Research Center, which provides care to children with severe life-limiting illness using a unique model that is highly regarded throughout the country. He also provides consultation on pediatric palliative care to hospitals regionally and nationally.